In Vitro Platform for Neurodegenerative Diseases

In Vitro Platform for Neurodegenerative Diseases
Version:
21334

Year:
2022

 

Explore Drug Knowledge in Pathological Phenotypes and Targets

 

Neurodegenerative disorder is a challenging therapeutic field defined as an unmet need. Investigating new targets and leveraging target combinations offer opportunities for better efficacy, safety, disease management, and life quality for patients. Eurofins Discovery provides three cost-effective panels for neurodegeneration, Alzheimer’s disease (AD), and Parkinson’s disease (PD) to evaluate candidates that modulate neurite and the multi-targeted mechanism of action (MOA).